Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating
TD Cowen Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $114
H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $120
Express News | HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $120 Price Target
A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $114 to $170
Praxis Precision Med Price Target Maintained With a $151.00/Share by Needham
BarfBag : Check out $Pagaya Technologies (PGY.US)$ solid AH